Literature DB >> 17651933

Nanostructured lipid carrier (NLC) based gel of celecoxib.

Medha Joshi1, Vandana Patravale.   

Abstract

Nanostructured lipid carriers (NLC) based topical gel of celecoxib was formulated for the treatment of inflammation and allied conditions. NLC prepared by the microemulsion template technique were characterized by photon correlation spectroscopy for size and scanning electron micrograph (SEM) studies. Drug encapsulation efficiency was determined using Nanosep centrifugal device. The nanoparticulate dispersion was suitably gelled and assessed for in vitro release and in vitro skin permeation using rat skin. Efficacy of the NLC gel was established using a pharmacodynamic study, i.e., aerosol-induced rat paw edema model. The skin permeation and rat paw edema pharmacodynamic studies were carried out in comparison with a micellar gel which had the same composition as that of the NLC gel except for the solid lipid and oil. The NLC based gel described in this study showed faster onset and elicited prolonged activity until 24h.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651933     DOI: 10.1016/j.ijpharm.2007.05.060

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  35 in total

1.  Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier.

Authors:  Musallam Almoussalam; Huijun Zhu
Journal:  J Vis Exp       Date:  2016-04-26       Impact factor: 1.355

2.  Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.

Authors:  Eder André Estracanholli; Fabíola Silva Garcia Praça; Ana Beatriz Cintra; Maria Bernadete Riemma Pierre; Marilisa Guimarães Lara
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

Review 3.  Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach.

Authors:  Ketki Bhise; Sushil Kumar Kashaw; Samaresh Sau; Arun K Iyer
Journal:  Int J Pharm       Date:  2017-05-11       Impact factor: 5.875

4.  Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line.

Authors:  Pooja Singh; Mahendra Singh; Jovita Kanoujia; Malti Arya; Shailendra K Saraf; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

5.  Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluation.

Authors:  Anju Malkani; Abhijit A Date; Darshana Hegde
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

6.  Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.

Authors:  Ram R Patlolla; Mahavir Chougule; Apurva R Patel; Tanise Jackson; Prasad N V Tata; Mandip Singh
Journal:  J Control Release       Date:  2010-02-11       Impact factor: 9.776

7.  Tailored Doxycycline Hyclate Loaded In Situ Gel for the Treatment of Periodontitis: Optimization, In Vitro Characterization, and Antimicrobial Studies.

Authors:  Ketan M Ranch; Furqan A Maulvi; Akshay R Koli; Ditixa T Desai; Rajesh K Parikh; Dinesh O Shah
Journal:  AAPS PharmSciTech       Date:  2021-02-17       Impact factor: 3.246

8.  Translocation of cell penetrating peptide engrafted nanoparticles across skin layers.

Authors:  Ram R Patlolla; Pinaki R Desai; Kalayu Belay; Mandip S Singh
Journal:  Biomaterials       Date:  2010-04-21       Impact factor: 12.479

Review 9.  Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.

Authors:  Anil Kumar; Fei Chen; Anbu Mozhi; Xu Zhang; Yuanyuan Zhao; Xiangdong Xue; Yanli Hao; Xiaoning Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanoscale       Date:  2013-09-21       Impact factor: 7.790

10.  Development and evaluation of ultra-small nanostructured lipid carriers: novel topical delivery system for athlete's foot.

Authors:  Samipta Singh; Mahendra Singh; Chandra Bhushan Tripathi; Malti Arya; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2016-02       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.